Analysis of surrogate markers for target-specific therapy in breast carcinomas using archival materialsSASANO, Hironobu; SUZUKI, Takashi; MORIYA, Takuya et al.Biomedicine & pharmacotherapy. 2007, Vol 61, Num 9, pp 543-547, issn 0753-3322, 5 p.Conference Paper

Permanent silencing of NKG2A expression for cell-based therapeuticsFIGUEIREDO, Constanca; SELTSAM, Axel; BLASCZYK, Rainer et al.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 2, pp 199-210, issn 0946-2716, 12 p.Article

Ki-67-directed Antisense therapy in an orthotopic renal cell carcinoma model. Editorial commentKAUSCH, I; JIANG, H; BROCKS, C et al.European urology. 2004, Vol 46, Num 1, pp 118-125, issn 0302-2838, 8 p.Article

Current concepts of organ preservation in head and neck cancerWANG, C.-J; KNECHT, R.European archives of oto-rhino-laryngology. 2011, Vol 268, Num 4, pp 481-487, issn 0937-4477, 7 p.Article

The Next Step: Innovative Molecular Targeted Therapies for Treatment of Intracranial Chordoma PatientsBARRY, Jeffrey J; JIAN, Brian J; SUGHRUE, Michael E et al.Neurosurgery. 2011, Vol 68, Num 1, pp 231-241, issn 0148-396X, 11 p.Article

The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258VALLO, Stefan; MANI, Jens; STASTNY, Matthias et al.Investigational new drugs. 2013, Vol 31, Num 2, pp 265-272, issn 0167-6997, 8 p.Article

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageTOVAR, Victoria; ALSINET, Clara; CABELLOS, Laia et al.Journal of hepatology. 2010, Vol 52, Num 4, pp 550-559, issn 0168-8278, 10 p.Article

Environmental risk factors for prevention and molecular intervention of cervical cancerAU, William W; ABDOU-SALAMA, Salama; SIERRA-TORRES, Carlos H et al.International journal of hygiene and environmental health. 2007, Vol 210, Num 6, pp 671-678, issn 1438-4639, 8 p.Article

Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injuryOYAIZU, Takeshi; FUNG, Shan-Yu; SHIOZAKI, Atsushi et al.Intensive care medicine (Print). 2012, Vol 38, Num 5, pp 894-905, issn 0342-4642, 12 p.Article

Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse modelBRENDEL, Cornelia; BELAKHOV, Valery; WERNER, Hauke et al.Journal of molecular medicine (Berlin. Print). 2011, Vol 89, Num 4, pp 389-398, issn 0946-2716, 10 p.Article

Molecular therapy in support to radiotherapyDUTREIX, M; COSSET, J. M; SUN, J.-S et al.Mutation research. Reviews in mutation research. 2010, Vol 704, Num 1-3, pp 182-189, issn 1383-5742, 8 p.Conference Paper

Erbliche blasenbildende Erkrankungen : Klinik, Diagnostik und Therapie der Epidermolysis bullosa : Pädiatrische Dermatologie, Teil II = Hereditary blistering diseaes. Symptoms, diagnosis and treatment of epidermolysis bullosaLAIMER, M; LANSCHÜTZER, C. M; NISCHLER, E et al.Der Hautarzt. 2009, Vol 60, Num 5, issn 0017-8470, 378-388 [11 p.]Article

Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markersBELL, Diana; HANNA, Ehab Y.Expert review of anticancer therapy. 2013, Vol 13, Num 3, pp 285-296, issn 1473-7140, 12 p.Article

Enzymatic Single-Chain Antibody Tagging: A Universal Approach to Targeted Molecular Imaging and Cell Homing in Cardiovascular DiseaseTA, H. T; PRABHU, S; WANG, X et al.Circulation research. 2011, Vol 109, Num 4, pp 365-373, issn 0009-7330, 9 p.Article

Malignant gliomas : strategies to increase the effectiveness of targeted molecular treatmentWEN, Patrick Y; KESARI, Santosh; DRAPPATZ, Jan et al.Expert review of anticancer therapy. 2006, Vol 6, Num 5, pp 733-754, issn 1473-7140, 22 p.Article

Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promiseCHRISTOPHER CHAMCHEU, Jean; WOOD, Gary S; SIDDIQUI, Imtiaz A et al.Experimental dermatology. 2012, Vol 21, Num 7, pp 481-489, issn 0906-6705, 9 p.Article

Novel S-Nitrosothiols Have Potential Therapeutic Uses for Cystic Fibrosis : Cystic Fibrosis: CFTR Modulators and their Mechanism of ActionZAMAN, Khalequz; FRASER-BUTLER, Maya; BENNETT, Deric et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 19, pp 3509-3520, issn 1381-6128, 12 p.Article

Molecular therapies in β-thalassaemiaQUEK, Lynn; SWEE LAY THEIN.British journal of haematology. 2007, Vol 136, Num 3, pp 353-365, issn 0007-1048, 13 p.Article

The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor ThrombusCOST, Nicholas G; DELACROIX JR, Scott E; RAJ, Ganesh V et al.European urology. 2011, Vol 59, Num 6, pp 912-918, issn 0302-2838, 7 p.Article

Abundant expression of mTOR kinase in salivary gland tumors ― potentials as therapy target?CLAUDITZ, Till Sebastian; GONTAREWICZ, Artur; BOKEMEYER, Carsten et al.Journal of oral pathology & medicine. 2013, Vol 42, Num 10, pp 769-773, issn 0904-2512, 5 p.Article

Pre-surgical targeted molecular therapy in renal cell carcinomaMARGULIS, Vitaly; WOOD, Christopher G.BJU international (Papier). 2009, Vol 103, Num 2, pp 150-153, issn 1464-4096, 4 p.Article

Molecular construction of bionanoparticles : chimaeric SIV p17-HIV I p6 nanoparticles with minimal viral protein contentCOSTA, Maria J. L; PEDRO, Luisa; ALVES DE MATOS, Antonio P et al.Biotechnology and applied biochemistry. 2007, Vol 48, pp 35-43, issn 0885-4513, 9 p., 1Article

Pathogenesis of lung cancer signalling pathways: roadmap for therapiesBRAMBILLA, E; GAZDAR, A.The European respiratory journal. 2009, Vol 33, Num 6, pp 1485-1497, issn 0903-1936, 13 p.Article

The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cellsMANDAL, M; KIM, S; YOUNES, M. N et al.British journal of cancer. 2005, Vol 92, Num 10, pp 1899-1905, issn 0007-0920, 7 p.Article

Epitheliale Tumoren der Haut: Molekulare Grundlagen und pathogenese-orientierte Therapie = Cutaneous epithelial tumors: Molecular biology and pathogenesis-based therapyREIFENBERGER, J; SCHÖN, M. P.Hautarzt. 2003, Vol 54, Num 12, pp 1164-1170, issn 0017-8470, 7 p.Article